Authors
Latest:
Handling IV Solutions Presents ChallengesPharmacies should ensure appropriate monitoring procedures are in place to prevent contamination and exposure.
Latest:
Social Determinants of Health Matter When Treating Patients With Breast CancerPharmacists play a critical role in treating patients with breast cancer and can help address their social determinant of health challenges.
Latest:
The Impact of Annual Neonatal and Pediatric Mock Code TrainingImplementation of yearly mock code training can reinforce essential knowledge and increase pharmacists’ clinical competence and confidence when faced with actual neonatal and pediatric emergencies.
Latest:
Lifileucel: A Novel Therapy for Metastatic Cutaneous MelanomaAdvancements in treatment include immune checkpoint inhibitors and BRAF/MEK inhibitors, though resistance remains a challenge, with lifileucel recently approved for previously treated metastatic cases.
Latest:
Technicians Play Key Roles in Health SystemsSeventeen percent work in hospital settings, including compounding, inpatient, medication reconciliation, and outpatient areas.
Latest:
Pharmacists’ Role in Antibiotic Stewardship: Understanding Spectrums to Combat ResistancePharmacists ensure responsible antibiotic use, combating resistance through tailored therapies.
Latest:
Overview of PARP Inhibitors in the Treatment of Ovarian CancerThere are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.
Latest:
AAN 2025: The Expanding Role of Precision Medicine in Alzheimer Disease, From Symptom Relief to Targeted CareNilufer Ertekin-Taner contrasts current one-size-fits-all Alzheimer disease treatments with the promise of precision medicine and emphasizes the vital role of collaborative, multidisciplinary care.
Latest:
Three Keys to Success for Pursuing a Career in the Biopharmaceutical IndustryBuilding a network, finding your passion, and taking steps to transition into an industry professional can help lead PharmD graduates to success.
Latest:
Pharmacists Can Help Treat Post-Intensive Care SyndromeManaging transitions of care is vital to discontinue use of unnecessary drugs and minimize medication errors.
Latest:
Approval of Tapinarof Introduces New Class of Topical Treatments for Management of Plaque PsoriasisTapinarof is a first-in-class topical steroid-free aryl hydrocarbon receptor antagonist intended to mitigate the symptoms of plaque psoriasis.
Latest:
Vaccination Conversations: Mastering Patient Q&A at the PharmacyWhen you’re unsure about answering a patient question, err on the side of caution and refer them to a pharmacist.
Latest:
The Community Pharmacist’s Role in the Management of MigraineMigraine is a chronic neurological disease characterized by throbbing or pulsating unilateral or bilateral headache that can last from hours to days.
Latest:
Inotuzumab Ozogamicin in Pediatric Patients With Relapsed or Refractory B-Cell ALLThis review discusses the significance of the FDA-approved drug inotuzumab ozogamicin in pediatric patients with acute lymphocytic leukemia (ALL) and relapsed/refractory (R/R) ALL, and the evolving therapeutic options in R/R ALL.
Latest:
NCPA President Discusses 3 Ways to Ride the Pharmacy Surge WaveImplement technology solutions, initiate clinical services, and shift to a proactive mindset, Michele Belcher says.
Latest:
Leveraging Technology to Enhance Women’s Health and Access to CarePanelists discuss how digital health technologies revolutionize women’s health care through telehealth, mobile apps, and remote monitoring, expanding access, personalization, and proactive medical support.
Latest:
Improving Transitions of Care for Patients Receiving Bispecific Therapies and Final RecommendationsPanelists discuss how key recommendations for optimizing bispecific therapy care focus on establishing robust communication protocols between academic and community centers while ensuring community centers develop comprehensive infrastructure including staff training, emergency protocols, and care coordination pathways.
Latest:
How Pharmacists Can Protect Patients from Outdated COVID-19 TreatmentThe pharmacist is the last barrier between a patient and a drug, which is why it's critical for pharmacists to check for allergies, potential drug interactions, patient understanding of how to use the drug, and whether the prescription is appropriate for the diagnosis.
Latest:
Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion ClinicPharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
Latest:
Pharmacists as Patient Advocates: Ensuring Optimal Therapeutic OutcomesPharmacists play a vital role in patient advocacy and health care collaboration by ensuring safe medication management, facilitating seamless care transitions, providing education, promoting adherence, and fostering compassion to enhance therapeutic outcomes and patient wellness.
Latest:
Current Good Manufacturing Practices Are Reliable SafeguardProperly implemented CGMP should not be seen as a regulatory burden but a remedy to poorly compounded drugs.
Latest:
TXNIP inhibitors: A New Class of Agents for Diabetes TreatmentTXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.
Latest:
Medically Integrated Pharmacies, Oral Oncolytic Agents Grow in Importance During COVID-19As practices have gained experience in the post-COVID-19 environment, health care professionals have found innovative ways to work around many of the obstacles the pandemic presents.
Latest:
What Does the FDA Panel’s MDMA Rejection Mean for the Future of Psychedelic Medicines?Although the committee's vote is non-binding, it does raise questions about optimal evaluation of psychedelics in clinical trials.
Latest:
Advancing Multistate Licensure Is Vital in Telehealth EraBut meeting regulatory requirements may entail a great deal of financial expertise and time.
Latest:
Pharmacists Play Role in Pharmacogenomics Clinical ServicesThey should consider many factors and use clear guidance on predicting phenotypes from genotypes to intervene optimally based on specific drug-gene interactions.
Latest:
Guideline Recommendations for LDL-C ManagementPanelists discuss how evolving clinical guidelines for intensive low-density lipoprotein cholesterol (LDL-C)–lowering therapies have shaped personalized treatment approaches through risk stratification, with different targets for primary vs secondary prevention and consideration of genetic factors when determining appropriate statin intensity.
